what is known already: The meiotic competence of oocytes depends on the follicle's potential to undergo appropriate maturation and is an important factor in infertility therapies such as IVF. The exact function of the GCs during follicular development remains unknown. study design, size, duration: After in vitro maturation (IVM) and ovulation induction of isolated ovarian pre-antral follicles from 12-day-old female C57BL6 mice (n ¼ 40), miRNA expression in the GCs was compared according to the maturity of the oocyte (metaphase I (MI) versus metaphase II (MII)). The miRNAs, which showed notable different expression, were modulated by transfection during IVM of follicles. materials, setting, methods: miRNA expression and candidate target gene expression in GCs of isolated murine ovarian preantral follicles were evaluated by real-time PCR after IVM. miR mimics and -inhibitors for selected miRNAs were transfected into the in vitro-maturated follicles, and ovulation, oocyte maturation and fertilization rates were compared. Candidate target gene expressions in GC were evaluated by quantitative PCR and immunohistochemistry using confocal microscopy.
Introduction
The meiotic competence of oocytes depends on the potential of follicles to undergo appropriate maturation (Swain and Pool, 2008) . During oocyte meiosis, ovulation and fertilization, each oocyte is surrounded by several layers of granulosa cells (GCs). GCs play an important role as mediators of follicular developmental potential via oocyte paracrine signals (Russell and Robker, 2007; Adriaenssens et al., 2009) . Many genes expressed in GCs have been reported to be under the control of both maternal and oocyte-derived signals, and it is suggested that their expression is representative of the maturational competence of oocytes (Gebhardt et al., 2011) .
The regulation of the transcriptome is a very complicated process. Traditionally, regulation of the transcriptome referred mainly to the activation or repression of gene expression by transcription factors. However, gene expression in higher organisms is now known to be controlled by a multi-layered regulatory network that includes epigenetic modifications of the genome and post-translational modifications of gene products. MicroRNAs (miRNAs) are endogenously produced noncoding RNA molecules that post-transcriptionally regulate gene expression by inhibiting the translation of or cleaving complementary target mRNAs (Bartel, 2009) . miRNAs inhibit translation by binding to the 3 ′ untranslated regions (UTR) of target mRNAs to promote RNA degradation (Ratner et al., 2010) . miRNA expression is measured by several procedures, which include microarrays, high-throughput sequencing and quantitative reverse transcriptase polymerase chain reaction (RT -PCR). Since the discovery of miRNA (lin-4) in Caenorhabditis elegans (Lee et al., 1997) , miRNAs have been found to play important roles in intracellular signaling, apoptosis, metabolism, organogenesis and development (Boutet et al., 2003; He and Hannon, 2004; Poy et al., 2004; Lai, 2005; Sokol and Ambros, 2005) . A recent study demonstrated that a mouse model with an affected miRNA-processing step has an infertile phenotype (Otsuka et al., 2008) . Although the synthesis and degradation of miRNAs are known to coexist in the preimplantation development of mouse embryos (Yang et al., 2008) , the miRNA expression profiles of GCs during oocyte maturation have not yet been detailed.
Ovarian follicle in vitro maturation (IVM) is a valuable experimental model for investigating the factors that control oocyte development at different developmental stages. Ovarian follicle IVM also aids in evaluating new clinical treatments for fertility preservation in patients undergoing chemotherapy and patients receiving alternative treatments for poor response to IVF cycles. Previous ovarian follicle IVM studies showed that hormones such as gonadotrophin and general culture conditions play important roles in oocyte maturation (Hartman et al., 2005; Panigone et al., 2008; Combelles et al., 2009; Zhang et al., 2009) .
Only a few studies have addressed changes in GC miRNA expression during follicle maturation. This study aimed to evaluate the miRNA expression profiles of GCs during IVM of mouse follicles and to determine the effects of GC miRNA expression on oocyte maturation. This study showed differences in the miRNA expression in the GCs of metaphase II (MII) and metaphase I (MI) oocytes and demonstrated changes in the meiotic and fertilization rates of oocytes where miRNA-expression in GCs was modulated experimentally.
Materials and Methods
Isolation and IVM of follicles, and the release of cumulus -oocyte complexes using hCG
The use of mice for this study was approved by the Institutional Animal Care and Use Committee. The methods used for isolation and IVM of follicles have been taken from previous studies (Liu et al., 2002; Kim et al., 2010) . C57BL6 mice were used for this study. Forty 12-day-old female mice were sacrificed by cervical dislocation. Their ovaries were removed and stored in Hank's balanced salt solution with 10% fetal calf serum (FCS). Early pre-antral follicles were mechanically dissected from the ovaries using a 28-gauge syringe needles (Becton Dickinson & Co, Franklin Lake, NJ, USA). The sharp tip of the needles was used to cut the surrounding stromal cells to release the follicles. Follicles (100 -120 mm in diameter), which contained layers of membrane-enclosed GCs with a centrally located, healthy, visible oocyte and superficial theca cells, were selected for culture. After removal of visibly atretic follicles, the selected pre-antral follicles were randomly cultured in micro-droplets (20 ml) in a culture dish (Falcon 3000; BD Biosciences, Irvine, CA, USA; 60 × 15 mm; 1 follicle per droplet, 25 droplets per dish) with media, covered with washed mineral oil, and incubated at 378C in 5% CO 2 for 12 days. Media were changed by refreshing half (10 ml) of the medium every other day. Morphological changes in the cultured follicles were evaluated under an inverted microscope (BX51WI; Olympus, Tokyo, Japan).
A total of 2500 isolated pre-antral follicles were selected from mice and cultured in the following conditions for 12 days with medium changed every other day: Opti-MEM medium (Invitrogen, Carlsbad, CA, USA) that contained 10 mg/ml of insulin plus 5% FBS with recombinant FSH (Gonal-F w ; Merck Serono, Geneva, Switzerland, 10/100 mIU/ml) and recombinant luteinizing hormone (LH) (Luveris w ; Merck Serono, 10/100 mIU/ml). Morphological characteristics of cultured follicles were recorded every other day. After 12 days of culture, 1.5 IU/ml of recombinant human chorionic growth hormone (hCG: Ovidrel w ; Merck Serono) plus 5 ng/ml human epidermal growth factor (EGF) were added to full-grown follicles with antral expansion to induce ovulation.
Degeneration rate and growth rate were evaluated after 12 days in culture; ovulation rates and oocyte maturation rates were assessed 36 h after hCG administration. A normal follicular structure contains a centrally located oocyte with surrounding layers of GCs within the basal membrane. Follicles were considered to have survived if they retained a normal structure with close contact between oocytes and the surrounding GCs. If a follicle did not show a normal structure during IVM culture, it was deemed to be degenerated. The degeneration rate was defined as the number of degenerated follicles divided by the number of total cultured follicles. Growth was evaluated by increasing outer follicle diameter and by antral formation. The growth rate was defined as the number of growing follicles divided by the number of total cultured follicles. The ovulation rate was defined as the number of ovulated follicles divided by the number of growing follicles. The oocyte maturation rate was defined as the number of MII oocytes divided by the number of ovulated oocytes. After mechanical denudation of the oocyte from surrounding GCs using a 28-gauge syringe needle with the expulsed cumulus -oocyte complex (COC), the released oocyte was classified as a germinal vesicle (GV) oocyte when the GV was present: as MI when the GV was broken down; as MII when the first polar body was extruded and as degenerated when the oocyte was dark, granulated, or fragmented.
Quantitative polymerase chain reaction for miRNAs and candidate target genes in mouse GCs
Using TRIzol w (Invitrogen), total RNA was extracted from GCs of follicles at MI and MII. With 100 pg of extracted total RNA, poly(A) tailing and complementary DNA (cDNA) synthesis for total miRNAs were performed using a commercial kit (NCode VILO miRNA cDNA Synthesis Kit; Invitrogen), as performed in a previous study (Kim et al., 2010) . Quantification of miRNAs by RT-PCR was performed according to the manufacturer's instructions (EXPRESS SYBR GreenER miRNA qRT-PCR Kit; Invitrogen). Briefly, 2 ml of the reverse transcription product was used as the template, and miRNA levels were measured using miRNA-specific PCR primers (1 ml), universal miRNA reverse primers (EXPRESS SYBR GreenER miRNA qRT-PCR Kit; 1 ml), and a commercial reagent (EXPRESS SYBR GreenER miRNA qRT-PCR Kit; Invitrogen; 10 ml). The total volume of the mixture for a single reaction was adjusted to 20 ml with DEPC-treated water. The miRNAs evaluated in this study are known to be expressed in mouse ovaries (http://www.microrna .org). The mouse miRNA-specific PCR primers used in this study are listed in Table I . RT-PCR was performed with a Rotor-gene instrument (Corbett Life Science, Sydney, New South Wales, Australia). The 20-ml reactions were incubated in a Light Cycler 3 quantitative RT-PCR machine at 958C for 10 min, followed by up to 60 cycles at 958C for 15 s and 608C for 30 s. miRNA measurements were normalized relative to those of mouse U6 RNA, and the relative level of miRNA expression was indicated as (Ct miRNA)/(Ct control RNA) (Torley et al., 2011) . Candidate miRNA target gene expression in GCs was similarly evaluated according to oocyte maturation. The expression was normalized relative to that of GAPDH RNA, and the relative expression was indicated as (Ct target gene)/(Ct control RNA). All the candidate target gene PCR primers used in this studyare listed in Table II .
Transfection of miRNAs into the IVM model of mouse follicles miRNA transfection was performed with a commercial reagent and predesigned sequences according to the manufacturer's instructions (Qiagen, Valencia, CA, USA). miScript miRNA mimics and inhibitors were used as predesigned sequences that were chemically synthesized double-stranded RNAs that mimic or inhibit mature endogenous miRNAs after transfection into cells. For miRNA-mimic sequence transfection, 37.5 ng of miScript miRNA Mimics [Syn-mmu-let-7b miScript miRNA Mimic (MSY0000522); Syn-mmu-let-7c miScript miRNA Mimic (MSY0000523); Syn-mmu-miR-27a miScript miRNA Mimic (MSY0000537); Syn-mmu-miR-322 miScript miRNA Mimic (MSY0000548), Qiagen] were diluted in 100 ml of follicle culture medium plus hCG and EGF without FCS to 5 nM final concentration. For miRNA-inhibitor sequence transfection, 187.5 ng of miScript miRNA inhibitor [Syn-mmu-let-7b miScript miRNA inhibitor (MIN0000522); Syn-mmu-let-7c miScript miRNA inhibitor (MIN0000523); Syn-mmu-miR-27a miScript miRNA inhibitor (MIN0000548); Syn-mmu-miR-322 miScript miRNA inhibitor (MSY0000548), Qiagen] was diluted in 100 ml of the same follicle culture medium as used for miRNA-mimics sequence transfection to a final concentration of 50 nM. HiPerFect Transfection Reagent (3 ml, Qiagen) was added into the diluted miRNA mimic and inhibitor reagents. Controls were prepared with only HiPerFect Transfection Reagent and diluting solution without miR mimics or inhibitors. After 12 days in culture, 1.5 IU/ml of recombinant hCG (Ovidrel w ; Merck Serono) plus 5 ng/ml human EGF were added to fullgrown follicles with antral expansion for ovulation. After 5-min incubation and removal of 10 ml of medium, the transfection complexes were added into the drop that surrounded the cultured follicles. Plates were gently swirled to ensure uniform distribution of the transfection complexes. After 36-h incubation, the follicles were observed and prepared for RNA extraction.
In vitro fertilization
After hCG supplementation, the COC was retrieved and oocyte maturity was evaluated after mechanical denudation of the cumulus by aspiration with a fine pipette. MII oocytes were collected in a culture dish. For IVF, 8-week old male C57BL6 mice were used for sperm collection. After sacrifice by cervical dislocation, the cauda epididymis and vas deferens were dissected. Using microforceps, fresh sperm were squeezed out and incubated at 378C in IVF medium (Universal IVF medium, Origio, Denmark) under 5% CO 2 for 1 h. Sperm motility and concentration were measured using an aliquot of diluted sperm suspension. More than 2.5 × 10 6 sperm/ml were assessed as the optimal motile sperm concentration. After fresh sperm was replaced into the fertilization dish, MII oocytes were transferred into the dish with a widebore pipette tip. After incubation at 378C in IVF medium (Universal IVF medium; Orgio) under 5% CO 2 for 4-6 h, oocytes were washed with several drops of medium to remove excess sperm and debris. Using an inverted microscope, fertilization was assessed by the presence of two pronuclei (2PN) and the extruded second polar body in fertilized oocytes. The fertilization rate was defined as the number of 2PN divided by the number of MII oocytes added to the sperm.
Statistical analysis
These experiments were repeated five times with different pools of samples. Means and standard deviations were compared using the Student's t-test. Differences were considered statistically significant when P , 0.05. All data were analyzed using the Statistical Package for the Social Sciences for Windows (version 12.0, SPSS, Inc., Chicago, IL, USA).
Results

Outcome of IVM of mouse ovarian follicles
After 12 days of culture, the in vitro matured follicles were fully grown, and ovulated COCs were obtained by ovulation induction with hCG Granulosa cell microRNAs and oocyte maturation supplementation. Zygotes were obtained following fertilization of MII oocytes from in vitro matured follicles, and the zygotes were cultured to the morula stage (Fig. 1) 
Difference in the miRNA profiles between the GCs of MI and MII oocytes
There were no significant differences in the follicle and ovulated COC morphology for MI and MII oocytes (Fig. 2) . MII oocytes possessed a visible first polar body, while MI oocytes did not. The relative expression (mean + SD) of mmu-let-7b (0.78 + 0.10, P ¼ 0.016), mmu-let-7c (0.78 + 0.12, P ¼ 0.029), mmu-miR-27a (0.57 + 0.18, P ¼ 0.016) and mmu-miR-322 (0.59 + 0.14, P ¼ 0.008) was significantly lowered in GCs of MII oocytes compared with those of MI oocytes (Fig. 3) .
Expression of miRNAs in GCs after miRNA-mimic and -inhibitor transfection
In the miRNA-mimic transfection groups, relative expression of the transfected miRNAs significantly increased in GCs compared with that in the controls [mmu-let-7b in mmu-let-7b-mimic transfection (1.44-fold, P ¼ 0.012), mmu-let-7c in mmu-let-7c-mimic transfection (1.84-fold, P ¼ 0.038), mmu-miR-27a in mmu-miR-27a-mimic transfection (1.83-fold, P ¼ 0.043) and mmu-miR-322 in mmu-miR-322-mimic transfection (1.63-fold, P ¼ 0.039)] (Fig. 4a) . In the miRNA-inhibitor transfection groups, the relative expression of the transfected miRNAs was significantly lower in GCs than in the controls [mmu-let-7b in mmu-let-7b-inhibitor transfection (0.88-fold, P ¼ 0.009), mmu-let-7c in mmu-let-7c-inhibitor transfection (0.80-fold, P ¼ 0.031), mmu-miR-27a in mmu-miR-27a-inhibitor transfection (0.42-fold, P ¼ 0.007) and mmumiR-322 in mmu-miR-322-inhibitor transfection (0.59-fold, P ¼ 0.039)] (Fig. 5a ). In contrast, there were no significant differences in the morphology of follicles and oocytes from the mmu-let-7b, mmu-let-7c, mmu-miR-27a, mmu-miR-322-mimic and mmu-miR-322-inhibitor transfection groups compared with the control (Fig. 4b and b) .
Effects of miRNA-mimic and -inhibitor transfection on oocyte maturation miRNA-mimic sequence transfection did not affect ovulation rates (Fig. 4c) . mmu-miR-27a mimic transfection showed a significantly lower oocyte maturation rate than that obtained for the control (9.4 versus 18.9%, P ¼ 0.042). There were no significant differences between these groups in terms of fertilization rate. miRNA-inhibitor sequence transfection also did not affect ovulation rates (Fig. 5c) . The mmulet-7c inhibitor, mmu-miR-27a and mmu-miR-322 transfections showed significantly higher oocyte maturation rates than the control (40.6, 31.6 and 30.5 versus 18.9%, P , 0.001, P ¼ 0.013, P ¼ 0.021, respectively). The fertilization rate of miRNA-inhibitor sequence transfection groups did not differ from that of the control.
Expression of candidate target genes in mouse GCs according to oocyte maturity
The expression of insulin growth factor-binding protein (IGFBP)-2 in mouse GCs of MII oocytes was 1.39-fold higher than in GCs of MI oocytes after follicle IVM (Fig. 6 ). The expression of insulin growth factor (IGF)-1, IGF-2, IGFBP-1, growth differentiation factor (GDF)-9, bone morphogenetic protein (BMP)-15, octamer-binding transcription factor (OCT)-4 and anti-Müllerian hormone (AMH) was similar for the GCs of MI and MII oocytes. The expression of IGFBP-2 in murine GCs was significantly lower than that in the control after mmu-let-7c-mimic, mmu-miR-27a-mimic and mmu-miR-322-mimic transfection, and the expression was significantly higher than that in the control after mmu-let-7b-mimic, mmu-let-7b-inhibitor, mmu-let-7c-inhibitor, mmumiR-27a-inhibitor and mmu-miR-322-inhibitor transfection as analyzed by RT -PCR (Fig. 7a) and immunohistochemistry (Fig. 7b ).
Discussion
We hypothesized that the expression profiles of miRNAs in GCs during development may differ according to the meiotic competence of their oocytes. To evaluate our hypothesis, we used an experimental model of an in vitro mouse follicle culture and ascertained the profile of miRNAs in human GCs according to oocyte maturity. When comparing GCs of MI and MII oocytes, the relative expression of mmu-let-7b, mmu-let-7c, mmu-miR-27a and mmu-miR-322 differed significantly. Notably, mmu-miR-27a and mmu-miR-322 expression showed significant down-regulation in the GCs of MII oocytes. This finding suggests that the candidate target RNA of the respective miRNAs may interfere more significantly in the GCs of MII oocytes compared with those of MI oocytes. These data are in line with previous studies on let-7 (Bao et al., 2011; Cayo-Colca et al., 2011; Takahashi et al., 2012) and miR-27a (Jennewein et al., 2010; Pathi et al., 2011; Zhou et al., 2011) as regulators of cell cycle signaling pathways, and studies on miR-322 as a modulator of ovarian development and folliculogenesis and cell differentiation (Ahn et al., 2010; Ghosh et al., 2010; Qin et al., 2010; Leem et al., 2011) .
In in vivo conditions, during the ovulation period, LH plays a key role in activating a cascade of signaling events that are propagated throughout the ovarian pre-ovulatory follicle to promote ovulation of a mature oocyte (Vaccari et al., 2009) . In experimental and clinical settings, hCG treatment mimics the endogenous LH surge because of its homology with LH (Brus et al., 1997; Moon et al., 2007) . Our study showed differences in oocyte maturation rates following transfection of mimics and inhibitors for specific miRNAs. These results suggest that modifying the miRNA profiles of GCs regulates the oocyte maturation rate during ovulation induction with hCG supplementation.
A recent study reported that miRNA transfection regulates apoptosis of GCs in mouse GC primary culture (Carletti et al., 2010) , which is supported by our data showing that the function of GCs can be modulated by miRNA transfection. Furthermore, we demonstrated that the modulation of miRNA in supporting cells may lead to control of adjacent oocyte maturation. This finding is intriguing considering that the enhancement of oocyte maturation rates can be beneficial via improvement in clinical IVF outcomes by allowing more mature oocytes to be fertilized (Beretsos et al., 2009; McAvey et al., 2011) .
Despite the changes in miRNA expression, no significant morphological differences were observed between the control and the miRNAmimic and miRNA-inhibitor transfection groups. Furthermore, similar ovulation rates were observed between the experimental groups. Taken together, miRNA-transfection seemed to have a limited effect on late follicular maturation, especially at the time of ovulation induction using hCG. Regarding the fertilization rate, miRNA transfection did not have any additional effect. It may be inferred that the process of sperm penetration involves activation factors from sperm in addition to oocyte acquisition by miRNAs transfection into GCs.
We compared nine candidate target genes selected by a web-database comparing GC gene expression between MI and MII oocytes. Among those genes, the expression of IGFBP-2 showed a difference between the GCs of MII oocytes and those of MI oocytes. The IGFBP-2 produced by GCs regulates the bioavailability of intrafollicular IGF during follicular development (Armstrong et al., 2001) . The ovarian IGF system is important during follicular development and previous studies have reported that the expression of IGFBP-2 increased in gonadotrophin-stimulated murine GCs (Hernandez et al., 1990; Spicer and Echternkamp, 1995; Wandji et al., 1998; Armstrong et al., 2000; Spicer, 2004) ; a cell-specific pattern of IGFBP-2 expression within COCs implies an interaction between the somatic and germinal compartments. A previous study has shown synchronized changes in the patterns of COC IGFBP-2 and FSHR expression during oocyte maturation, which suggests possible synergistic actions between the IGF and FSH system (Nuttinck et al., 2004) . Our data showing a change in IGFBP-2 expression following miRNA transfection was in agreement with these prior studies. Thus, it can be inferred that the transfection of miRNA inhibitors into GCs induces up-regulation of target genes such as IGFBP-2, leading to an increased oocyte maturation rate, possibly via modulating the unbound fraction of IGFs. In accordance with our data, some previous studies have suggested that miRNAs can modulate various endogenous IGFs and IGFBPs on various cells (Tanno et al., 2005; Liao and Lonnerdal, 2010) . Intriguingly, let-7b and let-7c have recently been reported to have different effects (Zhang et al., 2013) , which may partially explain the discrepancy between the two groups in our study.
Our study has some limitations. First, an in vitro model was used in lieu of an in vivo model because of the ease of performing miRNA transfections in cell culture. However, it must be noted that studies have shown similarities in and differences between in vivo and in vitro cultured follicles (Parrish et al., 2011; Sato et al., 2012) . The significant findings of the present study should be worth examining further in an IVM model of immature oocytes in vivo. Secondly, the present study could not provide direct evidence for the link between the expression of IGFBP-2 in GCs and the meiotic competence of oocytes. The findings of the present study need to be confirmed using in vivo maturation models and extended to evaluate the relevance with developmental competence.
In conclusion, miRNA expression profiles of GCs during IVM of murine follicles are associated with the maturity of adjacent oocytes. Modulation via miRNA transfection could regulate oocyte maturation efficiency during IVM of ovarian follicles.
